UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Increased by AdvisorNet Financial Inc

AdvisorNet Financial Inc boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 52.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,340 shares of the healthcare conglomerate's stock after purchasing an additional 3,917 shares during the quarter. AdvisorNet Financial Inc's holdings in UnitedHealth Group were worth $5,939,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director John H. Noseworthy acquired 300 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on UNH. Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Truist Financial reaffirmed a "buy" rating and issued a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Oppenheimer decreased their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft reduced their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. Finally, Wells Fargo & Company dropped their price objective on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.

UnitedHealth Group Stock Up 1.0%

Shares of UNH traded up $2.91 during midday trading on Friday, reaching $301.08. 16,265,624 shares of the company were exchanged, compared to its average volume of 6,787,922. The company has a market cap of $273.12 billion, a price-to-earnings ratio of 19.42, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a 50-day moving average price of $430.87 and a 200-day moving average price of $494.23. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the firm posted $6.91 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.